Volume | 28,416 |
|
|||||
News | - | ||||||
Day High | 0.529 | Low High |
|||||
Day Low | 0.50 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Exicure Inc | XCUR | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.518 | 0.50 | 0.529 | 0.5001 | 0.509 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
113 | 28,416 | $ 0.5111704 | $ 14,525 | - | 0.3647 - 1.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:52:53 | formt | 200 | $ 0.5237 | USD |
Exicure Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.32M | 8.65M | - | 28.83M | -2.58M | -0.30 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Exicure News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XCUR Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.57 | 0.596 | 0.50 | 0.5334461 | 16,972 | -0.0463 | -8.12% |
1 Month | 0.61 | 0.728 | 0.50 | 0.6073679 | 43,918 | -0.0863 | -14.15% |
3 Months | 0.545 | 0.793 | 0.50 | 0.6519295 | 230,087 | -0.0213 | -3.91% |
6 Months | 0.6583 | 0.86 | 0.3647 | 0.599614 | 515,288 | -0.1346 | -20.45% |
1 Year | 0.92 | 1.50 | 0.3647 | 0.6222251 | 270,783 | -0.3963 | -43.08% |
3 Years | 1.80 | 3.24 | 0.0846 | 0.370539 | 2,620,817 | -1.28 | -70.91% |
5 Years | 2.20 | 3.84 | 0.0846 | 0.516703 | 1,779,930 | -1.68 | -76.20% |
Exicure Description
Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. |